Vantage

Clinical Insight for Your Entire Organization

Access disease-level, longitudinal, oncology patient data to inform life science research, development, and commercial strategies with Vantage.

Use Cases

Make Better Decisions Across Therapy Lifecycle

From R&D to post marketing and HEOR, Vantage helps oncology biopharma teams identify opportunities and create enterprise level strategies for specific cancer diagnoses.

Pre-Marketing
Inform R&D strategy, optimize trial design, or create an ECA to support regulatory submission.
Commercial and Post-Marketing

Conduct Phase IV and HEOR studies and optimize commercial strategy.

Group 125
Group 134
Vector

COTA by the Numbers

2.1M+ Cancer Patient Lives

50/50 Academic vs. Community Treatment Setting

3 Approvals Supported

9 Hematology and Solid Tumor Diagnoses

5-Year Average Follow-up

2X Higher Inclusion Percentage in ECA vs. Competitor

Quality Real-World Data for Hematologic and Solid Tumor Diagnoses

COTA’s database of patients includes longitudinal treatment and outcomes data for oncology patients including:

Heme/Onc:

Solid Tumors:

Group 127
Group 161 (1)
Additional Support

Get the Most of Your Vantage Data with Real-World Insights and Support

Group 133
Resources

Fueling the Future of Cancer Research

Explore our collection of clinical research, recent press, podcasts, and more.

Group 134 (1)

Real-world data gets high marks for feasibility in lung cancer research: A cross-industry collaboration is advancing RWD

The real world is an unpredictable place.  It can be messy and confusing, full of challenges and uncertainties that have...

Light the Night: Bringing hope to patients during Blood Cancer Awareness Month

September is Blood Cancer Awareness Month, a time to bring extra attention to the more than 1.6 million people living...

COTA and Panalgo Q&A

COTA Spokesperson: C.K. Wang, Chief Medical Officer Panalgo Spokesperson: Meg Richards, PhD, MPH, Executive Director of Scientific Strategy Abbreviated answers...

Get a Better View with Vantage

Discover the power of real-world cancer data for your life science organization.